Phio Pharmaceuticals
PHIO
#10283
Rank
NZ$20.36 M
Marketcap
NZ$1.84
Share price
24.44%
Change (1 day)
-41.59%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -NZ$13.69 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$11.78 Million, an increase over its 2023 earnings that were of -NZ$17.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$13.69 Million16.19%
2024 -NZ$11.78 Million-33.96%
2023 -NZ$17.84 Million-5.7%
2022 -NZ$18.92 Million-13.6%
2021 -NZ$21.89 Million51.09%
2020 -NZ$14.49 Million-1.28%
2019 -NZ$14.68 Million21.03%
2018 -NZ$12.13 Million-53.1%
2017 -NZ$25.86 Million74.49%
2016 -NZ$14.82 Million-12.02%
2015 -NZ$16.85 Million16.17%
2014 -NZ$14.5 Million-57.95%
2013 -NZ$34.47 Million62.45%
2012 -NZ$21.22 Million0.87%
2011 -NZ$21.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.27 Billion 1,905.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$29.91 Million 128.29%๐Ÿ‡บ๐Ÿ‡ธ USA